Optimal utilisation of sulphonylureas in resource-constrained settings

ABSTRACT: Sulphonylureas (SUs) are oral anti-diabetic drugs (OADs) that were introduced more than 60 years ago. Clinicians are familiar with their use and they remain extensively used. However, the SU class is associated with adverse effects of weight gain and hypoglycaemia. In addition, their effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Poobalan, Rambiritch, Virendra, Butkow, Neil, Saman, Selvarajah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026768/
https://www.ncbi.nlm.nih.gov/pubmed/24844554
http://dx.doi.org/10.5830/CVJA-2014-007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026768/
https://www.ncbi.nlm.nih.gov/pubmed/24844554
http://dx.doi.org/10.5830/CVJA-2014-007

Ejemplares similares